Halozyme Therapeutics and Avid Bioservices have expanded their commercial supply agreements and entered a long-term strategic relationship. Halozyme has also designated Avid as a preferred supplier for future products requiring Avid’s process development and biomanufacturing capabilities. Avid has manufactured commercial product for Halozyme since 2005 in the company’s cGMP facility. As part of the new agreements, the companies extended their existing commercial supply agreement f...